InsideTrading SEC Form 4 insider trades
← PYXS insider activity
PYXS

Wadhane Jitendra

Other C-suite at Pyxis Oncology, Inc. 3 purchase filings, 0 sale rows in the last ten years

Record of purchases at this company

The stock's return minus its benchmark's, from the first open after each purchase was filed. IPO and offering allocations are left out. Past results of a few purchases, not a forecast.

Record of this insider's purchases by horizon
After Purchases Median Mean Above the benchmark
5 trading days 3 +18.6% +18.3% 3 of 3
21 trading days 3 +0.2% -1.3% 2 of 3
63 trading days 3 -13.2% -15.3% 0 of 3
126 trading days 3 +129.8% +127.9% 3 of 3

Purchases

This insider's purchase filings, newest first, with the return against the benchmark that followed
Filed Traded Shares Value 21 days vs benchmark63 days vs benchmark126 days vs benchmark Flags
2023-09-27 2023-09-27 2,500 $4.7K -8.2% (-16.0% raw)-20.6% (-4.3% raw)+137.1% (+156.1% raw)
2023-09-25 2023-09-25 5,000 $8.8K +0.2% (-6.5% raw)-13.2% (+3.6% raw)+129.8% (+150.0% raw)
2023-09-22 2023-09-22 2,500 $4.4K +4.2% (-0.6% raw)-12.3% (+3.4% raw)+116.9% (+135.0% raw)